HOME >> BIOLOGY >> NEWS
Blood test for colon cancer risk to be goal of Hopkins project

An interdisciplinary team of scientists from Johns Hopkins and elsewhere has been selected to receive a $2.25 million, five-year grant from the Doris Duke Charitable Foundation to develop a practical test to predict a person's risk of colon cancer by looking for a particular biological marker in the blood.

If successful, the test could be broadly applied to identify those who most need to be monitored with invasive but standard colonoscopy or who should make changes in their diet or in other factors to help lower their risk of developing colon cancer.

The researchers' test is based on the fact that five percent to 10 percent of people have improper control of a growth-promoting gene called insulin-like growth factor 2 or IGF-2. The Johns Hopkins scientists reported in February that, in mice, the double dose of IGF-2 protein sets the stage for cancer development -- by increasing the number of primitive cells found in the colon -- and that early evidence suggests the same could be true in people.

"If everything works out -- if IGF-2 status is tied to colon cancer risk in people and the blood test is workable -- then IGF-2 status could be the colon cancer equivalent of cholesterol levels as a risk factor for heart disease," says Andrew Feinberg, M.D., Ph.D., professor of medicine at Johns Hopkins and one of the leaders of the project. "We've never had a broad molecular screening tool like that for any cancer."

But there's a lot of work to do first. With the new Doris Duke Charitable Foundation grant, part of the foundation's Clinical Interfaces Award Program, Feinberg and his colleagues will develop and validate the blood test, study how IGF-2 status changes over time and evaluate whether IGF-2 status is a predictor of colon cancer. Patients will be enrolled at Johns Hopkins Hospital and at the Cleveland Clinic Foundation in Ft. Lauderdale, Fla.

"We've long suspected that genomic changes underlie cancer risk, but that knowledg
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
9-Sep-2005


Page: 1 2 3

Related biology news :

1. Blood test may help signal tumors remission, return in throat cancer patients
2. Blood sugars manufacture limited by building blocks supply
3. Bloods clotting cells harbor ticking time bombs, finding may help extend blood supply
4. Blood tests may be possible for mental health conditions
5. Cord Blood Registry achieves industry-leading stem cell recovery with new automation technology
6. Blood test predicts cardiac events and death in heart patients
7. Blood clot fibers more elastic than spiders web
8. Blood-compatible nanoscale materials possible using heparin
9. Blood pressure medication may revolutionize treatment of Marfan syndrome
10. Blood levels of suspected carcinogen vary by race, ethnicity
11. Blood conservation strategies take center stage at Emory University Hospital forum

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... 2019 , ... Join the live session on ... topics in data quality, including:, ,     State of the art ...     Smartphone and wearable based performance measures ,     Data quality analytics ...
(Date:1/10/2019)... ... 10, 2019 , ... When Dr. James L. Sherley, M.D., Ph.D., founder and ... a chapter to the new book Perinatal Stem Cells: Research and Therapy, he knew ... a debilitating secret of stem cell medicine. For more than a half-century, stem ...
(Date:1/8/2019)... ... January 07, 2019 , ... Join industry experts Julie Peacock, Client Services at ... on Thursday, January 17, 2019 at 1pm EST. , This webinar will ... clinical trial process. Featured speakers will also present a case study of a leading ...
Breaking Biology News(10 mins):
(Date:1/7/2019)... ... 07, 2019 , ... Kainos Medicine Inc. today announced that ... code-named "KM-819." KM-819 is an orally active small molecule that is a ... , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was to evaluate ...
(Date:1/4/2019)... DIEGO (PRWEB) , ... January 03, 2019 , ... ... at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the founding ... Biotherapeutics to receive critical input and guidance from key leaders in the Immuno-Oncology ...
(Date:12/18/2018)... (PRWEB) , ... December 17, 2018 , ... ... today the second cohort of emerging biosciences ventures invited to participate in the ... education to develop fundable business plans and a professional network. All startups receive ...
(Date:12/13/2018)... , ... December 11, 2018 , ... ... doctors and nurses can use to quickly detect Clostridium difficile (C. diff), a ... heart of a handheld device that can be used onsite in doctor’s offices ...
Breaking Biology Technology:
Cached News: